Molecular docking analysis of metformin analogues with GSK-3β

Ponnu Lakshmi Rajagopal; Vidhya Rekha Umapathy; Sandhya P; Fathima Jh; Ramajayam Govindan; Chella Perumal Palanisamy; Vishnu Priya Veeraraghavan; Selvaraj Jayaraman

doi:10.6026/97320630018269

Molecular docking analysis of metformin analogues with GSK-3β

Bioinformation. 2022 Mar 31;18(3):269-272. doi: 10.6026/97320630018269. eCollection 2022.

Authors

Ponnu Lakshmi Rajagopal¹, Vidhya Rekha Umapathy², Sandhya P³, Fathima Jh⁴, Ramajayam Govindan⁵, Chella Perumal Palanisamy⁶, Vishnu Priya Veeraraghavan⁷, Selvaraj Jayaraman⁷

Affiliations

¹ Central Research Laboratory, Meenakshi Academy of Higher Education and Research (Deemed to be University), Chennai, India.
² Department of Public Health Dentistry, Sree Balaji Dental College and Hospital, Pallikaranai, Chennai-600 100, India.
³ Department of Biochemistry, Allied Health science, Dr. M.G.R Educational and Research Institute, Chennai India.
⁴ Department of Oral and Maxillofacial Pathology, Ragas Dental College and Hospitals, Chennai, India.
⁵ Multi Disciplinary Research Unit, Madurai Medical College, TamilNadu, India.
⁶ State Key Laboratory of Bio-based Materials and Green Papermaking, College of Food Science and Engineering, Qilu University of Technology, Shandong Academy of Science, Jinan 250353, China.
⁷ Department of Biochemistry, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.

Abstract

We report the molecular docking analysis of four analogues of metformin [1-Carbamimidoyl-1,2-dimethylguanidine hydrochloride, Metformin hydrochloride, N1,N1-Dimethyl-N5-methylbiguanide hydrochloride, and N1,N1,N5,N5-Tetrakis (methyl-biguanide hydrochloride] with GSK3.

Keywords: Diabetes mellitus; GSK-3β; Metformin analogues; Molecular docking studies.